HSDT
Price
$4.35
Change
-$0.24 (-5.23%)
Updated
May 21 closing price
Capitalization
5.17M
STE
Price
$246.33
Change
-$4.14 (-1.65%)
Updated
May 21 closing price
Capitalization
22.22B
81 days until earnings call
Interact to see
Advertisement

HSDT vs STE

Header iconHSDT vs STE Comparison
Open Charts HSDT vs STEBanner chart's image
Helius Medical Technologies
Price$4.35
Change-$0.24 (-5.23%)
Volume$13.32K
Capitalization5.17M
STERIS
Price$246.33
Change-$4.14 (-1.65%)
Volume$533.41K
Capitalization22.22B
HSDT vs STE Comparison Chart
Loading...
HSDT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HSDT vs. STE commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSDT is a Buy and STE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (HSDT: $4.35 vs. STE: $246.33)
Brand notoriety: HSDT and STE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HSDT: 109% vs. STE: 79%
Market capitalization -- HSDT: $5.17M vs. STE: $22.22B
HSDT [@Medical Specialties] is valued at $5.17M. STE’s [@Medical Specialties] market capitalization is $22.22B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSDT’s FA Score shows that 0 FA rating(s) are green whileSTE’s FA Score has 2 green FA rating(s).

  • HSDT’s FA Score: 0 green, 5 red.
  • STE’s FA Score: 2 green, 3 red.
According to our system of comparison, STE is a better buy in the long-term than HSDT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSDT’s TA Score shows that 6 TA indicator(s) are bullish while STE’s TA Score has 7 bullish TA indicator(s).

  • HSDT’s TA Score: 6 bullish, 2 bearish.
  • STE’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, HSDT is a better buy in the short-term than STE.

Price Growth

HSDT (@Medical Specialties) experienced а +0.93% price change this week, while STE (@Medical Specialties) price change was +8.28% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.03%. For the same industry, the average monthly price growth was +8.10%, and the average quarterly price growth was -0.30%.

Reported Earning Dates

HSDT is expected to report earnings on Mar 25, 2025.

STE is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (+1.03% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STE($22.2B) has a higher market cap than HSDT($5.17M). STE has higher P/E ratio than HSDT: STE (38.85) vs HSDT (0.14). STE YTD gains are higher at: 20.143 vs. HSDT (-56.736). STE has higher annual earnings (EBITDA): 1.39B vs. HSDT (-10.99M). STE has more cash in the bank: 196M vs. HSDT (6.6M). HSDT has less debt than STE: HSDT (70K) vs STE (3.51B). STE has higher revenues than HSDT: STE (5.41B) vs HSDT (792K).
HSDTSTEHSDT / STE
Capitalization5.17M22.2B0%
EBITDA-10.99M1.39B-1%
Gain YTD-56.73620.143-282%
P/E Ratio0.1438.850%
Revenue792K5.41B0%
Total Cash6.6M196M3%
Total Debt70K3.51B0%
FUNDAMENTALS RATINGS
HSDT vs STE: Fundamental Ratings
HSDT
STE
OUTLOOK RATING
1..100
1213
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
18
Undervalued
PROFIT vs RISK RATING
1..100
10034
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6518
P/E GROWTH RATING
1..100
10054
SEASONALITY SCORE
1..100
46n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STE's Valuation (18) in the Medical Specialties industry is in the same range as HSDT (36). This means that STE’s stock grew similarly to HSDT’s over the last 12 months.

STE's Profit vs Risk Rating (34) in the Medical Specialties industry is significantly better than the same rating for HSDT (100). This means that STE’s stock grew significantly faster than HSDT’s over the last 12 months.

STE's SMR Rating (100) in the Medical Specialties industry is in the same range as HSDT (100). This means that STE’s stock grew similarly to HSDT’s over the last 12 months.

STE's Price Growth Rating (18) in the Medical Specialties industry is somewhat better than the same rating for HSDT (65). This means that STE’s stock grew somewhat faster than HSDT’s over the last 12 months.

STE's P/E Growth Rating (54) in the Medical Specialties industry is somewhat better than the same rating for HSDT (100). This means that STE’s stock grew somewhat faster than HSDT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HSDTSTE
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
57%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
58%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 6 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
56%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
50%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
55%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
HSDT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONON59.14-0.53
-0.89%
On Holding AG
ARTL0.95-0.01
-1.42%
Artelo Biosciences
TALK2.90-0.09
-3.17%
Talkspace
TOI2.67-0.10
-3.78%
Oncology Institute (The)
IMVT14.41-0.59
-3.93%
Immunovant

HSDT and

Correlation & Price change

A.I.dvisor indicates that over the last year, HSDT has been loosely correlated with STSS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HSDT jumps, then STSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSDT
1D Price
Change %
HSDT100%
-5.23%
STSS - HSDT
36%
Loosely correlated
-7.07%
HSCS - HSDT
32%
Poorly correlated
-13.14%
A - HSDT
24%
Poorly correlated
-4.03%
STE - HSDT
24%
Poorly correlated
-1.65%
SHC - HSDT
23%
Poorly correlated
-3.74%
More

STE and

Correlation & Price change

A.I.dvisor indicates that over the last year, STE has been loosely correlated with SYK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STE
1D Price
Change %
STE100%
-1.65%
SYK - STE
53%
Loosely correlated
-2.52%
DHR - STE
51%
Loosely correlated
-5.54%
WAT - STE
51%
Loosely correlated
-4.07%
RVTY - STE
50%
Loosely correlated
-4.01%
LH - STE
50%
Loosely correlated
-3.77%
More